Robert Bostwick, Ph.D., joined Southern Research (SR) in February 2013. In his current role as director of the High-Throughput Screening Center at SR, he oversees the management and screening of large compound libraries in biochemical and cell-based assays for government and commercial clients, as well as academic collaborations. In addition he directs the SR biology efforts involved in lead generation for proprietary drug discovery programs.
Bostwick’s expertise includes developing biochemical and cell-based assays employing methodologies across multiple technology platforms amenable to HTS. His breadth of experience also includes conducting and managing research projects, directing scientific operations, and building scientific programs and teams to successfully execute them.
From March 2011 until joining SR, Bostwick served as Executive Director of Jubilant Discovery Services, a subsidiary of Jubilant Life Sciences. Prior to that, he worked at AstraZeneca and its legacy companies from March 1993. During his 18 year tenure there, he held various levels of responsibilities where he served in project, group, section, and department leadership roles.
Prior to working in the pharmaceutical industry, Bostwick was an assistant professor in the Department of Neurology at Baylor College of Medicine, where he investigated neuronal development. He received adoctorate in biochemistry from the University of Houston and a bachelor’s degree in science with a double major in zoology/psychology from Duke University.